Mathias Uhlen

Deputy Chairman
Pharma
Affibody Medical
Norway

Business Expert Pharmaceutical Sciences
Biography

Prof. Uhlén is a co-founder of Affibody AB, and Professor of Biotechnology at the Royal Institute of Technology in Stockholm. He is a Program Director of the Swedish Human Protein (HPA) program, funded by the Knut and Alice Wallenberg foundation, and a Board member of Atlas Antibodies AB (Chairman), Antibodypedia AB (Chairman), Bure AB, Novozymes AS, Atlasab Intressenter AB and SweTree Technologies AB

Research Intrest

Biotechnology,Human Protein

Global Scientific Words in Pharmaceutical Sciences